OXGENE - Ownership and Business Overview

Life ScienceCompany

OXGENE Ownership

Who owns OXGENE?

OXGENE is owned by WuXi AppTec. It was acquired on March 2, 2021.

OXGENE Business Overview

Where is OXGENE headquartered?

OXGENE is headquartered in Oxford, United Kingdom.

What sector is OXGENE in?

OXGENE is a life science company.

When was OXGENE founded?

OXGENE was founded in 2011.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 391 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 345 by strategics.

OXGENE

Oxford Genetics Ltd.

Medawar Centre, Robert Robinson Avenue,
Oxford, OX4 4HG
United Kingdom,
+44 (0) 1865 415 107
www.oxgene.com

OXGENE provides end-to-end contractual services to cell and gene therapy companies seeking to discover, develop, manufacture and test innovative drugs at scale for global commercialization. OXGENE provides rapid and cost-effective services using proprietary technologies and automation platforms for molecular discovery and integrating the full range of technologies required to manufacture cell and gene therapies. OXGENE was founded in 2011 and is based in Oxford, United Kingdom.


 Subscribe to unlock this and 206,651
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.